[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [PBNCategory](https://github.com/mm80843/T3.5/tree/pages/docs/PBNCategory/index.md) >> Individual ID:PBN__PBNCategory_1 

# __Effective control and elimination of infectious pathogens to prevent disease transmission and reduce the overall risk of infection.__

## Items covered in this category

* [Averted/delayed infections](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1022.md)
* [Contactless delivery and disinfection](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1184.md)
* [Control over spread of infection](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_995.md)
* [Controlling infection](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1119.md)
* [Destruction of pathogens](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1.md)
* [Dilution and removal of infectious particles in room air](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_650.md)
* [Disease transmission reduction](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_30.md)
* [Early detection of reinfections](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_700.md)
* [Effective management and disposal of potentially infected waste](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_967.md)
* [Effective treatment](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_100.md)
* [Estimating state of infection](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_495.md)
* [Estimation of true number of infections](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1188.md)
* [Inactivation of deposited pathogens](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_430.md)
* [Inactivation of infectious microorganisms](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1041.md)
* [Inactivation of pathogens](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1266.md)
* [Killing or inhibition of germs](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_498.md)
* [Lower infection rates](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_609.md)
* [Pathogen inactivation](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_503.md)
* [Pathogenesis](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_317.md)
* [Prolonged antimicrobial activity](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_504.md)
* [Proper handling and isolation of infected workers](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_429.md)
* [Reduced airborne pathogen concentration](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_342.md)
* [Reduced number of infected people](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_849.md)
* [Reduced pathogen concentration](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_347.md)
* [Reduced risk of infection](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_934.md)
* [Reduced risk of reinfection](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1297.md)
* [Reduced transmission of influenza](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_511.md)
* [Reduction in disease incidence](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_313.md)
* [Reduction in infection rates](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_316.md)
* [Reduction in infections](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_431.md)
* [Reduction in infectiousness](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_315.md)
* [Reduction in tb infection](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_335.md)
* [Reduction in total infections](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1333.md)
* [Reduction in total number of infections](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1325.md)
* [Reduction in transmission of respiratory syncytical virus](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1189.md)
* [Reduction of airborne pathogens](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_837.md)
* [Reduction of disease spread and contamination](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1327.md)
* [Reduction of hospital acquired infections](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_939.md)
* [Reduction of infection](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_917.md)
* [Reduction of infections](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_591.md)
* [Reduction of pathogen spread](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_596.md)
* [Reduction of pathogens in the air](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_770.md)
* [Removal of other respiratory pathogens](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_825.md)
* [Retention of virucidal potency after multiple exposures to the virus](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_888.md)
* [Segregation of infected individuals](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1045.md)
* [Slowed growth rate of infections](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1117.md)

## Title of the category

This category of Benefits describes various aspects related to the prevention and control of contagious diseases within infrastructure, specifically in green buildings neighborhoods. It includes measures such as estimating the state of infection, lower infection rates, reduced transmission of specific viruses like respiratory syncytial virus and influenza, as well as the reduction of airborne pathogen concentration. Other benefits encompass the destruction and inactivation of pathogens, reduction of infections and disease incidence, dilution and removal of infectious particles in room air, effective management of potentially infected waste, control over the spread of infection, and proper handling and isolation of infected individuals. Additional advantages consist of slowed growth rate of infections, averted or delayed infections, reduced tuberculosis infection, effective treatment, estimation of true number of infections, reduced number of infected people, prolonged antimicrobial activity, early detection of reinfections, retention of virucidal potency, removal of other respiratory pathogens, reduced risk of reinfection, inactivation of deposited pathogens, reduction of hospital-acquired infections, contactless delivery and disinfection, segregation of infected individuals, reduction of pathogen spread, and killing or inhibition of germs.

